Atlas Trials

Nurix Therapeutics, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Nurix Therapeutics, Inc.

RecordFirmDate
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL (NCT07516093)Nurix Therapeutics, Inc.2026-06-01
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies (NCT07520006)Nurix Therapeutics, Inc.2026-05-01
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201) (NCT07221500)Nurix Therapeutics, Inc.2025-10-15
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers (NCT06717269)Nurix Therapeutics, Inc.2024-11-30
Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948 (NCT06691828)Nurix Therapeutics, Inc.2024-11-01
A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects (NCT06593457)Nurix Therapeutics, Inc.2024-08-20
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies (NCT05131022)Nurix Therapeutics, Inc.2022-04-13
A Study of DeTIL-0255 in Adults With Advanced Malignancies (NCT05107739)Nurix Therapeutics, Inc.2021-12-22
A Study of NX-1607 in Adults With Advanced Malignancies (NCT05107674)Nurix Therapeutics, Inc.2021-09-29
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies (NCT04830137)Nurix Therapeutics, Inc.2021-05-05

Track Nurix Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.